Quent Capital’s Radiopharm Theranostics RADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$371 Buy
+229
New +$641 ﹤0.01% 1618

Other funds holding RADX

Quent Capital's RADX Position: Q3 2026 in Review

Quent Capital opened a new position in Radiopharm Theranostics (RADX) in Q3 2026: 229 shares worth $371. The stake represents ﹤0.01% of the portfolio and ranks #1618 among its holdings.

8 funds tracked by Wall St. Rank hold RADX as of Q3 2026.

  • Quent Capital held 229 shares of Radiopharm Theranostics worth $371 as of Q3 2026.
  • Radiopharm Theranostics was a new Quent Capital position in Q3 2026.
  • Radiopharm Theranostics made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1618 holding.
  • 8 funds tracked by Wall St. Rank held Radiopharm Theranostics as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.